For: | Yang FY, Shao L, Su J, Zhang ZM. Carrimycin in the treatment of acute promyelocytic leukemia combined with pulmonary tuberculosis: A case report. World J Clin Cases 2024; 12(3): 623-629 [PMID: 38322455 DOI: 10.12998/wjcc.v12.i3.623] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v12/i3/623.htm |
Number | Citing Articles |
1 |
Zimo Wang, Xiaodong Li, Weiyan Zhang, Lei Fu, Xinda Li, Xiaoyou Chen, Yu Lu, Rosemary C. She.
Efficacy of carrimycin against
Mycobacterium avium
complex
in vitro
and
in vivo
. Microbiology Spectrum 2025; doi: 10.1128/spectrum.02422-24
|
2 |
Ethambutol/Isoniazid/Rifampicin. Reactions Weekly 2024; 2014(1): 269 doi: 10.1007/s40278-024-61697-y
|
3 |
Luca Guarnera, Emiliano Fabiani, Giulia Falconi, Giorgia Silvestrini, Maria Luigia Catanoso, Mariadomenica Divona, Maria Teresa Voso. Acute Promyelocytic Leukemia-like AML: Genetic Perspective and Clinical Implications. Cancers 2024; 16(24): 4192 doi: 10.3390/cancers16244192
|
4 |
Ning Du, Dan You, Dava Tenzing, Dongxiang Qu, Jun Meng, Yihui Wang, Juan He. Carrimycin, as One of the Drugs in Combination Therapy, for the Treatment of Carbapenem-Resistant Acinetobacter Baumannii Infection. Infection and Drug Resistance 2024; : 3617 doi: 10.2147/IDR.S468413
|